Grant name: Assay Validation of High Quality Markers for Clinical Studies in Cancer
Funding organization: National Cancer Institute (NCI), National Institutes of Health (NIH)
Total funding amount: Up to $250,000 per year
Duration: Maximum project period of 3 years
Primary objective: To validate biomarkers and assays for cancer detection, diagnosis, prognosis, and treatment response
Key stakeholders: Scientific investigators, oncologists, statisticians, clinical laboratory scientists
Funding source: Federal government
Funding type: Cooperative agreement
Significance: Addresses critical barriers in cancer research by validating assays for clinical use
Grant frequency: One-time funding opportunity
Eligible organization types: Higher Education Institutions, Nonprofits, For-Profit Organizations, Local Governments, State Governments, County Governments, City or Township Governments, Indian/Native American Tribal Governments, Federal Government agencies, and others
Specific qualifications: Assays must be analytically validated
Geographic location: U.S. based organizations
Previous relationship with funder: Not specified
Organizational maturity: Not specified
Primary focus areas: Cancer detection, diagnosis, prognosis, and treatment response
Target beneficiaries: Cancer patients and healthcare providers
Geographic coverage: U.S.
Expected outcomes: Clinical validation of assays
Sustainability expectations: Not specified
Technical expertise: Must have experience in assay validation
Infrastructure: Access to clinical laboratory facilities
Team composition: Must include clinical investigators and laboratory staff
Quality standards: Assays must meet CLIA certification if used for medical decision-making
Budget range: Up to $250,000 per year
Eligible costs: Direct costs related to assay validation
Matching fund requirements: Not specified
Payment schedule: Not specified
Open date: January 19, 2024
Application due dates: Multiple deadlines until October 14, 2026
Earliest start date: February 20, 2024
Regulatory compliance: Must adhere to NIH policies
Data protection: Must comply with applicable regulations
Ethical standards: Must ensure ethical conduct in research
Required documentation: Follow the Research Instructions in the Application Guide
Application procedure: Submit through Grants.gov
Evaluation criteria: Scientific merit and relevance to cancer research
Focus on existing assays rather than new technology development
Encouragement of multidisciplinary collaboration
This is a reissue of a previous funding opportunity (PAR-20-314)
No specific historical recipient data provided